Title:
OPHTHALMIC COMPOSITION CONTAINING CLATHRATED ANTIOXIDANT SUBSTANCE, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/235939
Kind Code:
A1
Abstract:
The present invention provides an ophthalmic composition and a use thereof. In one embodiment of the present invention, an ophthalmic composition containing a clathrated antioxidant substance is provided. In some of embodiments of the present invention, a composition for treating or preventing an ophthalmic disease, an ophthalmic disorder or an ophthalmic symptom is provided, wherein the ophthalmic disease, the ophthalmic disorder or the ophthalmic symptom includes, but is not limited to, dry eye or a dry eye-like ophthalmic disease, conjunctivitis, corneal ulcer, age-related macular degeneration, cataract, pseudoexfoliation syndrome, and symptoms in these diseases which can be ameliorated by increasing the quantity of tears and/or goblet cells and/or mucin.
More Like This:
| JP2008523130 | Pyrrole derivative with CRTH2 receptor antagonist activity |
| WO/2010/119698 | HEAD-AND-NECK TUMOR PROLIFERATION INHIBITOR |
| WO/2001/038392 | NOVEL TRANSCRIPTION FACTOR AND DNA THEREOF |
Inventors:
QIN JUNWEN (JP)
TAKAHASHI YUJI (JP)
KAKUTA SHIGERU (JP)
KYUWA SHIGERU (JP)
TAKAHASHI YUJI (JP)
KAKUTA SHIGERU (JP)
KYUWA SHIGERU (JP)
Application Number:
PCT/JP2018/023780
Publication Date:
December 27, 2018
Filing Date:
June 22, 2018
Export Citation:
Assignee:
TK HEALTH RES CO LTD (JP)
UNIV TOKYO (JP)
UNIV TOKYO (JP)
International Classes:
A61K45/00; A61K9/08; A61K31/01; A61K31/015; A61K31/12; A61K31/122; A61K31/202; A61K47/40; A61P27/02; A61P27/04; A61P27/12; A61P43/00
Domestic Patent References:
| WO2016057871A1 | 2016-04-14 |
Foreign References:
| JP2015027980A | 2015-02-12 | |||
| JP2007505040A | 2007-03-08 | |||
| JP2010065014A | 2010-03-25 | |||
| JP2016034918A | 2016-03-17 |
Attorney, Agent or Firm:
YAMAMOTO Shusaku et al. (JP)
Download PDF: